Anti-IGFBP3 antibody
Specifications
| Product Cat#: | AB-06-2363 |
| Product type: | Primary antibody |
| Antigen: | IGFBP3 |
| Immunogen: | KLH conjugated synthetic peptide derived from human IGFBP3 186-292/292 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:800-1:2000); Immunohistochemistry-Paraffin (1:500-800); Immunofluorescence; Immunocytochemistry (1:80-1:200) |
| Reactivity: | Mouse, Rat and Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | IGF BP3 |
| IGF-BP3 | |
| Acid stable subunit of the 140 K IGF complex | |
| Binding protein 29 | |
| Binding protein 53 | |
| BP 53 | |
| BP53 | |
| Growth hormone dependent binding protein | |
| IBP 3 | |
| IBP3 | |
| IGF binding protein 3 | |
| IGFBP 3 | |
| IGFBP-3 | |
| Insulin like growth factor binding protein 3 |
Show More
Target information
IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Also exhibits IGF-independent antiproliferative and apoptotic effects mediated by its receptor TMEM219/IGFBP-3R.
Provider
Erpantech Laboratory